O
EVH icon

OppenheimerFunds’s Evolent Health EVH Stock Holding History

OppenheimerFunds’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-813,523
Closed -$14.5M – 1849
2017
Q3 		$14.5M Buy
813,523
+69,132
+9% +$1.42M 0.02% 667
2017
Q2 		$18.9M Buy
744,391
+6,316
+0.9% +$152K 0.02% 573
2017
Q1 		$16.5M Buy
738,075
+59,075
+9% +$1.13M 0.02% 639
2016
Q4 		$10M Buy
679,000
+60,790
+10% +$1.2M 0.01% 755
2016
Q3 		$15.2M Buy
+618,210
New +$14.5M 0.02% 646

Other funds holding EVH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
FG
Formula Growth Montreal, Quebec, Canada $222M AUM 27.84% 1-Year Est. Return

OppenheimerFunds's EVH Position: Q4 2017 in Review

OppenheimerFunds sold out of Evolent Health (EVH) in Q4 2017, closing a stake of 813,523 shares — an estimated $14.5M sold.

OppenheimerFunds first reported a position in EVH in Q3 2016 and held it in 5 quarters. The position peaked at $18.9M in Q2 2017. 156 funds tracked by Wall St. Rank hold EVH as of Q4 2017.

  • OppenheimerFunds reported no remaining Evolent Health position as of Q4 2017 after selling out during the quarter.
  • OppenheimerFunds sold 813,523 Evolent Health shares in Q4 2017, an estimated $14.5M.
  • OppenheimerFunds first reported a position in Evolent Health in Q3 2016 and held it in 5 quarters.
  • OppenheimerFunds's Evolent Health position peaked at $18.9M in Q2 2017.
  • 156 funds tracked by Wall St. Rank held Evolent Health as of Q4 2017.

Based on OppenheimerFunds's 13F filing for Q4 2017, filed 12 Feb 2018.